Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
EditForce Logo
EditForce Growth Score
27
CB Rank
68850
Heat Score
64
EditForce develops drugs and seeds by using nucleic acid manipulation technologies.
Founded
obfuscation
PrivateVenture - Series Unknown Fukuoka, Fukuoka, Japan11-50 www.editforce.co.jp/
Biotechnology
Medical
Nursing and Residential Care
Overview

EditForce
Total Funding
obfuscation
Growth Score
27
Heat Score
64

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score27
-5 pts
in past quarter
Heat Score 64
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About EditForce

CB Rank
68850
EditForce develops drugs and seeds by using nucleic acid manipulation technologies.
Founded
obfuscation
PrivateVenture - Series Unknown Fukuoka, Fukuoka, Japan11-50 www.editforce.co.jp/
Biotechnology
Medical
Nursing and Residential Care

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name EditForce Inc., Edit Force Co., Ltd.
Also Known As エディットフォース
Operating Status Active
Company Type For Profit
Founders  Takahiro Nakamura
About the Company
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.
Phone Number +81 092-802-4935
Contact Email editforce-info@editforce.jp
Predictions & Insights

Products & Services

PPR Platform Technology
An RNA editing technology based on PPR proteins that enables targeted manipulation of RNA sequences for gene editing and regulation.
Gene Therapy Drug Development Using PPR Platform
Research and development of gene therapy drugs that use PPR platform technology to regulate genes at the RNA level with selectable drug delivery systems.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown
obfuscation
Venture Round - EditForce Logo
Venture Round - EditForce
3
obfuscation
Newton BiocapitalVenture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 6 Board Members and Advisors 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 18, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

660
55.66%
 in past month

Active Website Tech Count

34EditForce is actively using 34 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

6The intellectual property of EditForce includes 6 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is EditForce's headquarters? EditForce is located in Fukuoka, Fukuoka, Japan.Who invested in EditForce? EditForce has 8 investors including Newton Biocapital and  Global Brain Corporation.When was the last funding round for EditForce? EditForce closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are EditForce's competitors? Alternatives and possible competitors to EditForce may include Alnylam Pharmaceuticals, Orbital Therapeutics, and  Metagenomi.How much funding has EditForce raised to date? EditForce has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|